Skip to content
10-Q

Quarterly Report

VITASPRING BIOMEDICAL CO. LTD.

0001640334-26-001046

← back to feed
Filed
Jun 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Jun 15, 2026 207.03M sh
Cash And Equivalents Q1 2026 · Apr 30, 2025 $0
Cash And Equivalents Q1 2026 · Jan 31, 2025 $272
Current Liabilities Q1 2026 · Apr 30, 2025 $4.11M
Current Liabilities Q1 2026 · Jan 31, 2025 $4.03M
Total Liabilities Q1 2026 · Apr 30, 2025 $4.11M
Total Liabilities Q1 2026 · Jan 31, 2025 $4.03M
Current Assets Q1 2026 · Apr 30, 2025 $295
Current Assets Q1 2026 · Jan 31, 2025 $272
Total Assets Q1 2026 · Apr 30, 2025 $11.91K
Total Assets Q1 2026 · Jan 31, 2025 $14.38K
Shares Diluted Q1 2026 · Apr 30, 2024 207.03M sh
Operating Cash Flow Q1 2026 · Apr 30, 2024 −$4.02K
Stockholders Equity Q1 2026 · Apr 30, 2024 −$3.53M
Stockholders Equity Q1 2026 · Jan 31, 2024 −$3.35M
Eps Diluted Q1 2026 · Apr 30, 2024 $0.00
Sga Expense Q1 2026 · Apr 30, 2024 $216.83K
Net Income Q1 2026 · Apr 30, 2024 −$216.83K
Operating Income Q1 2026 · Apr 30, 2024 −$216.83K
Revenue Q1 2026 · Apr 30, 2024 $0